Technical and economic feasibility of reusing Medical Devices to reduce the costs of procedures

It’s very common practice to reuse medical devices in the West and if implemented in India, then it can bring down the cost of procedures. Officials from Maharashtra state Food and Drug Administration (FDA), Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY), and the State’s medical insurance scheme discussed the possibilities to reuse the devices as this can reduce the costs of the medical procedures.

Discussions are at a preliminary stage but if it adopted then major surgeries can be done at low costs. But top hospitals that have refused to be a part of MJPJAY may change their mind.

Chief Executive Officer Dr. Sudhakar Shinde of MJPAY said that only one meeting held to discuss this and there is a full possibility that it will also be discussed at a national level under the Pradhan Mantri Jan Arogya Yojana (PMJAY). In West, Catheters, balloons and guide wires were reused widely and dedicated agencies take care of sterilizing and repackaging the device for reuse in many countries. Pallavi Darade, FDA commissioner said infection control is very important as to reuse medical devices as chances of infection are there.

Ms. Darade said it’s not as simple as it seems and a lot of things should need to handle like how many times they can be reused, sterilization standards.  Deep analysis of this issue is required. FDA in 2017, had pulled up a number of hospitals for reusing drug-notified medical devices on multiple patients and charged them without taking its consent. Many of the hospitals are reusing them after sterilization by ethylene oxide treatment, but only a few were doing so to genuinely cut costs for patients.

Dr. Prafulla Kerkar, Cardiologist specialist from the civic-run KEM Hospital shared that no absolute clarity is there from regulatory authorities on the aspect of reuse of medical devices. He also shared that presently, the FDA mentioned labeled the devices as single-use devices or single-use disposables. All the stakeholders have to come together to arrive at a consensus and clarity on this aspect, he said.

All stakeholders should have to come together to arrive at a consensus and clarity on this aspect.

Related Posts

Chandigarh News: Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered – Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered

Chandigarh:  A case has been registered against a pharmaceutical company for trying to mislead PGI by creating a fake letter from CDSCO (Central Drugs Standard Control Organisation) Baddi to prove…

Kushinagar News: Truck Was Traveling From Ghaziabad To Agartala, Mystery Revealed When It Overturned

Case of codeine syrup being hidden among sugar sacks in a truck. After receiving the documents, the pharmaceutical department sent them to Ghaziabad and Agartala and started investigation. Kushinagar/Rahsu Bazaar.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Mandates Label Updates On CAR-T Cancer Therapies

US FDA Mandates Label Updates On CAR-T Cancer Therapies

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs